SCM
SCPH

Stonepine Capital Management’s scPharmaceuticals SCPH Stock Holding History

Stonepine Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-347,687
Closed -$914K – 81
2025
Q1 		$914K Sell
347,687
-335,843
-49% -$1.09M 0.89% 24
2024
Q4 		$2.42M Sell
683,530
-95,344
-12% -$365K 1.95% 17
2024
Q3 		$3.55M Buy
778,874
+357,171
+85% +$1.73M 2.24% 15
2024
Q2 		$1.83M Sell
421,703
-25,073
-6% -$110K 1.67% 12
2024
Q1 		$2.24M Buy
+446,776
New +$2.5M 1.78% 10

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Stonepine Capital Management's SCPH Position: Q2 2025 in Review

Stonepine Capital Management sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 347,687 shares — an estimated $914K sold.

Stonepine Capital Management first reported a position in SCPH in Q1 2024 and held it in 5 quarters. The position peaked at $3.55M in Q3 2024. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

  • Stonepine Capital Management reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 347,687 scPharmaceuticals shares in Q2 2025, an estimated $914K.
  • Stonepine Capital Management first reported a position in scPharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Stonepine Capital Management's scPharmaceuticals position peaked at $3.55M in Q3 2024.
  • 97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.